Sarkozi L, Szabo A
Department of Chemistry, Mount Sinai School of Medicine, City University of New York, N.Y.
Clin Physiol Biochem. 1989;7(3-4):184-8.
Phosphate retention is commonly associated with chronic renal failure. Previously we presented a technique to calculate the distribution of phosphate constituents in body fluids. We studied it in pre- and postdialysis serum of 62 patients. After hemodialysis, there was some decrease in the concentration of each constituent, with significant changes in the molar fraction of H2PO4- and CaHPO4. There is a significant negative correlation between the molecular mass of the constituent (X) and the effect of dialysis (Y): urea and H2PO4- 50%; NaHPO4-, HPO4(2-), and creatinine 41-44%; MgHPO4 39%, and CaHPO4 28%. Y = 69.7 - 0.26x, r = -0.833, p less than 0.001. This limited removal of CaHPO4 may contribute to the vascular calcification and peripheral ischemic necrosis of chronic uremic patients.
磷潴留通常与慢性肾衰竭相关。此前我们提出了一种计算体液中磷成分分布的技术。我们在62例患者透析前和透析后的血清中对其进行了研究。血液透析后,每种成分的浓度均有一定程度下降,其中H2PO4-和CaHPO4的摩尔分数有显著变化。成分的分子量(X)与透析效果(Y)之间存在显著负相关:尿素和H2PO4-为50%;NaHPO4-、HPO4(2-)和肌酐为41 - 44%;MgHPO4为39%,CaHPO4为28%。Y = 69.7 - 0.26x,r = -0.833,p < 0.001。CaHPO4这种有限的清除可能导致慢性尿毒症患者的血管钙化和外周缺血性坏死。